At the heart of every product developed by ActiveImmunity lies rigorous scientific research and validation. Since the beginning, the company has remained committed to translating laboratory insights into safe, effective, and accessible solutions that enhance immune health. Whether addressing the needs of humans or animals, ActiveImmunity builds each formula on a foundation of evidence, precision, and innovation.
Building on Evidence
Each IgY-based formulation undergoes extensive lab testing to ensure it targets specific pathogens and remains stable through digestion or topical use. The company’s research team works closely with microbiologists, immunologists, and biochemists to optimize the antibody response, ensuring that every product achieves high-impact results.
Key Achievements
- Neutralization efficiency of up to 99% for specific bacterial strains
- Validated applications in gastroenterology, dermatology, and veterinary medicine
- Successful scale-up from laboratory to full production without compromising antibody activity
Ongoing Innovation
ActiveImmunity is continuously advancing its scientific platform through academic partnerships, international patent development, and a focus on sustainability. Its proprietary low-temperature extraction method not only preserves IgY bioactivity but also supports the creation of personalized, pathogen-specific formulas. Every step forward brings the company closer to redefining what preventive healthcare can look like.
Science is not just where ActiveImmunity starts — it’s what drives every innovation. Through transparency, ethical practices, and clinically grounded research, the company is building a new standard for immune support — one rooted in biology, powered by technology, and focused on long-term wellbeing.
